Target intelligence / Profile preview

SRY-box transcription factor 8 (SOX8)

Target
SOX8
Molecular classification
Transcription factor, DNA-binding protein, SOX family, HMG-box protein
01

Overview

SRY-box transcription factor 8 (SOX8) is a member of the SOX (SRY-related HMG-box) family of transcription factors, which are key regulators of embryonic development and cell fate determinations[4][5][6][7]. SOX8 functions by binding to DNA and influencing the transcription of genes involved in neurodevelopment, oligodendrocyte differentiation, and myelination within the central nervous system, as well as in limb and facial morphogenesis. It acts primarily as a transcriptional activator in complex with partner proteins. SOX8 is expressed in various tissues but is especially important in oligodendrocyte maturation and myelin maintenance; its deficiency has been associated with delayed remyelination and developmental deficits, and SNPs near SOX8 have been implicated in multiple sclerosis risk[1][3]. Abnormal SOX8 expression or loss-of-function is linked to male infertility, neurodevelopmental syndromes (such as ATR-16), and certain cancers, most strongly hepatocellular carcinoma, where it may enhance tumor cell proliferation[4][5].

Other names
Transcription factor SOX-8SOX8SRY (sex determining region Y)-box 8SRY-box 8
02

Biological functions

Regulation of embryonic developmentDetermination of cell fateCentral nervous system developmentLimb and facial developmentMyelin maintenance in oligodendrocytesPossible role in male sex determination
03

Disease associations

Cancer (notably hepatocellular carcinoma)Neurological disorders (multiple sclerosis, disorders with demyelination)Developmental disorders (cognitive/mental disabilities, e.g., ATR-16 syndrome)Male infertilityPeripheral demyelinating neuropathyWaardenburg syndromeHirschsprung disease
04

Safety considerations

No direct safety concerns noted; as a transcription factor, therapeutic targeting may pose specificity challenges[4][5][7].

Beyond the preview

Go deeper on SRY-box transcription factor 8 (SOX8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRY-box transcription factor 8 (SOX8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call